|
Delayed
Nasdaq
03:02:06 31/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2.630 USD | -2.59% |
|
-5.05% | +85.21% |
| 16/10 | Edesa Biotech, Inc. Receives FDA IND Clearance For Phase 2 Clinical Study Of EB06 In Vitiligo | CI |
| 20/08 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.59% | -5.05% | -37.53% | -49.90% | +85.21% | +40.64% | -16.51% | -95.57% | - | 36.48M | |
| -0.62% | +0.50% | -11.61% | +12.26% | +56.67% | +33.92% | +60.07% | +2.90% | - | 64.38B | |
| +0.35% | +3.20% | -4.68% | +8.12% | +12.61% | +14.92% | +84.55% | +205.18% | +5,665.71% | 56.16B | |
| +0.53% | +1.96% | +12.00% | +12.98% | +19.78% | +15.37% | +106.81% | -15.59% | +244.86% | 54.16B | |
| -3.62% | -5.28% | -1.58% | +11.28% | +17.39% | +22.24% | +49.36% | +2.21% | +268.85% | 45.33B | |
| +0.24% | -1.15% | +2.01% | +15.90% | +22.87% | +21.11% | +100.03% | +4.43% | +1,022.98% | 42.25B | |
| -0.51% | +1.02% | -7.97% | -1.70% | +137.16% | +220.87% | +929.40% | +506.99% | - | 40.78B | |
| +3.27% | +47.96% | +66.97% | +112.15% | +92.99% | +112.67% | +96.48% | +36.35% | +249.91% | 33.8B | |
| +1.22% | -1.39% | +7.10% | +6.44% | +11.15% | +13.92% | +46.95% | +16.23% | +160.92% | 32.25B | |
| -1.29% | -1.72% | -16.86% | +12.95% | +41.48% | +21.00% | -6.85% | -62.43% | - | 23.57B | |
| -1.23% | +0.03% | -10.34% | -5.07% | -7.42% | -15.79% | -5.48% | -67.87% | - | 22.39B | |
| +0.81% | +20.60% | -1.32% | +10.98% | -35.28% | -42.01% | +373.24% | +262.74% | +767.72% | 24.37B | |
| -3.60% | -2.25% | +4.80% | +13.12% | +16.47% | +12.72% | +170.54% | +188.93% | +2,154.20% | 18.95B | |
| -5.48% | +3.07% | +20.66% | +51.72% | +78.44% | +98.74% | +116.36% | -19.15% | +369.11% | 17.95B | |
| +0.73% | +3.57% | +16.96% | +27.87% | +40.58% | +44.70% | +87.72% | -15.33% | +111.94% | 16.88B | |
| +8.29% | +11.17% | +22.82% | +28.18% | +63.68% | +84.23% | +254.45% | +230.60% | +577.43% | 16.4B | |
| -0.70% | +3.38% | +10.43% | +0.21% | - | - | - | - | - | 16.62B | |
| -3.19% | +13.19% | +23.36% | +26.69% | +15.08% | +26.84% | -11.94% | -27.42% | +161.22% | 16.14B | |
| -4.03% | +2.59% | -0.42% | +10.19% | +180.86% | +166.14% | +341.90% | +1,407.09% | +787.81% | 15.77B | |
| -7.86% | +6.50% | -12.08% | +62.59% | +21.95% | -16.53% | - | - | - | 14.05B | |
| Average | -0.86% | +6.12% | +4.14% | +18.35% | +45.88% | +46.09% | +154.28% | +142.24% | +964.82% | 28.61B | |
| Weighted average by Cap. | -0.56% | +5.03% | +4.64% | +19.40% | +41.55% | +45.19% | +163.46% | +120.93% | +1,262.89% |
- Stock Market
- Stocks
- EDSA Stock
- Sector Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
